A comparative clinical study on the effect of Tagara (Valeriana wallichii DC.) and Jatamansi (Nardostachys jatamansi DC.) in the management of Anidra ( XXXX ).

@entity1 @entity22
INTRODUCTION: The World Health Organization's 2004 Global Burden of Disease report indicated 3.6 million years of productive, healthy life is lost worldwide as a result of @entity22 . Approximately 30-35% of @entity1 meet diagnostic criteria for @entity22 characterized by impairment resulting from problems of falling and staying asleep. AIMS: To evaluate the effect of Tagara (Valeriana wallichii DC.) and Jatamansi (Nardostachys jatamansi DC.) in the management of Anidra. MATERIALS AND METHODS: A total of 34 @entity1 were selected fulfilling the criteria for inclusion for @entity22 were randomly selected from Out @entity1 Department and In @entity1 Department of Manasa Roga and assigned into two groups, wherein 30 @entity1 completed the study (15 in each). Tagara Churna (powder of V. wallichii) and Jatamansi Churna (powder of N. jatamansi) in the dose of 4 gm with milk was administered three times a day for a period of 1 month. RESULTS: Tagara provided significant improvement in @entity22 (76.00%; P < 0.001), duration of sleep (55.17%; P < 0.001), disturbed sleep (69.58%; P < 0.001), and disturbances in routine work (73.95%; P < 0.001). Jatamansi provided improvement in @entity22 (61.34%; P < 0.001), duration of sleep (48.25%; P < 0.001), disturbed sleep (53.08%; P < 0.001), and disturbance in routine works (43.85%; P < 0.001). CONCLUSION: Both the groups showed good results, but Tagara group showed better results in comparison to Jatamansi group.
